Abstract: A fuel cell vehicle includes a fuel cell stack connected to a direct current (DC) link, an energy storage device selectively connected to the DC link through a main relay, and a controller configured to determine whether or not starting of the fuel cell stack is allowed according to a voltage of the energy storage device, and to control starting of the fuel cell stack based on a result of the determination.

Abstract: A memory device including a memory cell array which includes a plurality of memory cells connected to each of a plurality of bit lines and word lines, a first bit line sense amplifier electrically connected to a first bit line through a first memory cell and a first connecting wiring and a second bit line sense amplifier electrically connected to a second bit line through a second connecting wiring having a length different from that of the first connecting wiring. A first compensation load of the first bit line and a second compensation load of the second bit line are adjusted to equalize RC loads of the first bit line and the second bit line.

Abstract: An embodiment method of controlling a fuel cell electric vehicle includes determining a required output power amount of a fuel cell stack from a total required output power amount of a battery and the fuel cell stack based on an output power distribution ratio of the fuel cell stack according to a current state of charge (SOC) value of the battery and controlling an operation of the fuel cell stack based on the required output power amount of the fuel cell stack.

Abstract: Lithium secondary batteries are disclosed. In an embodiment, a lithium secondary battery includes an anode including an anode active material that includes carbon-based active material particles including carbon, the carbon-based active material particles having a Brunauer-Emmett-Teller (BET) specific surface area of 3.0 m2/g to 5.0 m2/g and an average particle diameter (D50) of 5?m to 7.5 ?m, a cathode facing the anode, and a non-aqueous electrolyte solution including a non-aqueous organic solvent that includes a propionate-based organic solvent including propionate and a lithium salt. A content of the propionate-based organic solvent relative to a total volume of the non-aqueous organic solvent is 55 vol % or more.

Abstract: A fuel cell vehicle includes a fuel cell stack and a battery, a drive motor configured to drive the vehicle through electrical energy of the fuel cell stack or the battery and to generate electric power through regenerative braking during braking, and a controller configured to set a limit of a regenerative braking output of a drive motor upon braking of the vehicle, taking into consideration a driving environment factor in an exterior of the vehicle, a vehicle manipulation factor of a vehicle driver, and a vehicle driving factor as to a driving state of a vehicle part including the fuel cell stack and the battery.

Abstract: A pixel includes first, second, and third sub-pixels each including an emission area and a non-emission area. Each of the first, second, and third sub-includes a pixel circuit layer; a first electrode on the pixel circuit layer; a pixel defining layer on the first electrode and including an opening to expose an area of the first electrode; an emission layer on the pixel defining layer; a second electrode on the emission layer; a thin film encapsulation layer over the second electrode; a color filter on the thin film encapsulation layer; and an overcoat layer over the color filter. The overcoat layer has a refractive index greater than a refractive index of the color filter. A color filter of the second sub-pixel overlaps a color filter of each of the first and third sub-pixels in the non-emission area.

Abstract: A lithium secondary battery includes a negative electrode, a positive electrode positioned opposite to the negative electrode, a separator disposed between the negative electrode and the positive electrode, and a non-aqueous electrolyte, wherein the negative electrode includes a silicon-based active material, the silicon-based active material comprises a compound represented by SiOx, wherein 0?x<2, the non-aqueous electrolyte includes a lithium salt, an organic solvent, and an additive, the additive includes a first additive and a second additive, the first additive includes a coumarin-based compound represented by Formula 1, and the second additive includes at least one of lithium fluoromalonato(difluoro)borate (LiFMDFB), lithium difluoro(oxalato)borate (LiDFOB), lithium difluorophosphate (LiDFP), or lithium difluorobis-(oxalate)phosphate (LiDFOP): wherein R and n are described herein.

Abstract: The present invention relates to a method for purification of hemopexin and haptoglobin and provides a method in which a solution containing hemopexin and haptoglobin is titrated to a range of specific pH values without a step of precipitating haptoglobin by salt addition, followed by separating and purifying hemopexin and haptoglobin individually.

Abstract: The present invention relates to a device for analyzing a bio-signal, and a method therefor, and the method for analyzing a bio-signal comprises the steps of: removing bio-signal noise generated by a sensor; estimating the signal quality of the bio-signal for a preset unit time; classifying the bio-signal for the preset unit time into an abnormal signal or a normal signal; and determining whether an abnormal state episode occurs and a duration time thereof on the basis of the signal quality of the bio-signal for a plurality of unit times and the result of the classification.

Abstract: The present invention relates to a device and a method for analyzing an abnormal physiological signal, and the method for analyzing an abnormal physiological signal comprises the steps of: removing bio-signal noise generated by a sensor; estimating the signal quality of the bio-signal for a preset unit time; performing classification of an atrial fibrillation (AF), which is an abnormal signal, on the bio-signal for the unit time to classify same into an AF, which is an abnormal signal, and a normal sinus rhythm (NSR), which is a normal signal; determining whether an AF episode, which is an abnormal state episode, occurs and a duration time thereof, on the basis of the signal quality of preset number of consecutive unit times and the result of the classification of the AF, which is an abnormal signal; and calculating the load of the AF, which is an abnormal signal, on the basis of whether an AF episode, which is an abnormal state episode, occurs and the duration time thereof.

Abstract: Disclosed is an oligonucleotide-modified nucleic acid containing at least one 1-?-D-arabinofuranosylcytosine as a modified nucleic acid having therapeutic efficacies and guanosine. More particularly, a novel oligonucleotide-modified nucleic acid containing at least one modified nucleic acid (N) having therapeutic efficacies and being rich in guanosine (G) is synthesized and the fact that the novel oligonucleotide-modified nucleic acid has excellent apoptotic activities on blood cancer cells and drug-resistant blood cancer cells is identified. Based on this, provided is a composition for preventing, ameliorating or treating blood cancer, containing the novel oligonucleotide-modified nucleic acid, and the novel oligonucleotide-modified nucleic acid or a pharmaceutically acceptable salt thereof as an active ingredient.

Abstract: A memory device is provided. The memory device comprises a memory cell array connected to a first bit line and a complementary bit line, a first bit line sense amplifier configured to sense, amplify and the first bit line signal output a first bit line signal and the complimentary bit signal output on a complementary bit line signal output on the first bit line and the complementary bit line, a charge transfer transistor connected to the first bit line sense amplifier and configured to be gated by a charge transfer signal of a first node, an offset transistor configured to connect the first node and a second node based on an offset removal signal and a pre-charging transistor connected between the second node and a pre-charging voltage line and the pre-charging transistor being configured to pre-charge the first bit line or the complementary bit line based on an equalizing signal.

Abstract: Provided is a medical implant including: an implant base having a surface made of a silicon material; a linker having one end attached onto the surface of the implant base; and a cytokine bound to another end of the linker. By inducing the secretion of anti-inflammatory cytokines, a capsular contracture, which is one of the complications that may occur after transplantation of the patient's breast implant, may occur less.

Abstract: An electronic device according to one embodiment of the disclosure includes a display, a memory that stores an application for editing an image, and a processor that outputs the image through the application onto the display. The processor may be configured to output, on the display, the image, a first guide indicating an area to be cropped in the image, and a preview corresponding to the first guide in a first mode of the application. The processor may output, on the display, an image changed in accordance with a second mode in response to a user input to change a mode from the first mode to the second mode. The processor may output a second guide corresponding to the second mode on the display such that the preview corresponding to the first guide is output. In addition, various embodiments understood through the specification are possible.

Abstract: The present invention relates to bacterial ghosts, and more particularly, to a method of preparing bacterial ghosts from gram-positive bacteria by hydrochloric acid treatment. Specifically, according to the present invention, when gram-positive bacteria were cultured after being treated with a minimum inhibitory concentration (MIC) of hydrochloric acid capable of inhibiting colony formation of gram-positive bacteria, bacterial ghosts were effectively formed. Since the formed bacterial ghosts have no intracellular proteins or DNA while preserving cell wall integrity, the risk of side effects such as secondary infection caused by bacterial growth when the bacterial ghosts are administered to humans is low. Therefore, the bacterial ghosts prepared from gram-positive bacteria according to the method of the present invention may be effectively used as a vaccine or a foreign antigen carrier for preventing or treating gram-positive bacterial infection.

Abstract: Disclosed is a protein complex, comprising a physiologically active polypeptide, a dimeric protein and a non-peptidyl polymer having three functional ends (3-arm), with the linkage of both the physiologically active polypeptide and the dimeric protein to the 3-arm non-peptidyl polymer via respective covalent bonds. The protein complex guarantees the long acting activity and biostability of a physiologically active polypeptide. Having the ability to maintain the bioactivity of physiologically active polypeptides or peptides highly and to significantly improve the serum half life of the polypeptides or peptides, the protein complex can be applied to the development of sustained release formulations of various physiologically active polypeptide drugs. Also, it utilizes raw materials including the physiologically active polypeptides without significant loss, thereby increasing the production yield. Further, it can be easily purified.

Abstract: An electronic device is provided. The electronic device includes a display, a memory configured to store instructions, and a processor, wherein the processor is configured to execute the stored instructions to display an image and a user interface (UI) representing depth information of the image through the display in response to a first user input for editing the image, receive a second user input for selecting an object to be added in the image, display at least a part of the object in the image based on a depth value of the object and depth information of a first region in which the object is located in the image, and display an indicator representing the depth value of the object in the UI.

Abstract: The present invention relates to a multi-hole stent for digestive organs, the multi-hole stent including: a body configured to form a plurality of cells through the intersection of wires and to be provided in a hollow cylindrical shape; and a film configured to be installed in contact with the inner surface of the body; wherein one or more discharge holes are formed in the film. The multi-hole stent for digestive organs is placed in a stenotic region in a biliary track, and can thus secure a discharge path by restoring a narrowed diameter. Furthermore, the film is installed on the inner surface of the body, and can thus prevent the entry of a lesion into the stent and re-stenosis attributable to the growth of the lesion and can thus provide discharge paths for body fluids generated from side branches through the discharge holes formed in the film.

Abstract: An electronic device according to one embodiment of the disclosure includes a display, a memory that stores an application for editing an image, and a processor that outputs the image through the application onto the display. The processor may be configured to output, on the display, the image, a first guide indicating an area to be cropped in the image, and a preview corresponding to the first guide in a first mode of the application. The processor may output, on the display, an image changed in accordance with a second mode in response to a user input to change a mode from the first mode to the second mode. The processor may output a second guide corresponding to the second mode on the display such that the preview corresponding to the first guide is output. In addition, various embodiments understood through the specification are possible.

Abstract: An electronic device is provided. The electronic device includes a memory storing spherical content, at least a portion of which is provided in the shape of at least a portion of a sphere with respect to a central point of an image, a display configured to output the spherical content, and a processor configured to be electrically connected with the memory and the display. The processor is configured to arrange a specified patch image on a central point of the spherical content when outputting the spherical content on the display. In addition, various embodiments ascertained through the specification are possible.